Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2011, Article ID 424986, 8 pages
http://dx.doi.org/10.4061/2011/424986
Review Article

Stem Cell-Based Approaches for the Treatment of Diabetes

1SAAD Centre for Pharmacy & Diabetes, Biomedical Sciences Research Institute, School of Biomedical Sciences, University of Ulster, Coleraine BT52 1SA, UK
2Institute for Science & Technology in Medicine, Keele University, Keele ST5 5BG, UK

Received 15 December 2010; Accepted 18 March 2011

Academic Editor: Claudio Napoli

Copyright © 2011 Catriona Kelly et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. A. Ryan, S. Imes, and C. Wallace, “Short-term intensive insulin therapy in newly diagnosed type 2 diabetes,” Diabetes Care, vol. 27, no. 5, pp. 1028–1032, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. N. D. Cohen and J. E. Shaw, “Diabetes: advances in treatment,” Internal Medicine Journal, vol. 37, no. 6, pp. 383–388, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. D. B. Kaufman, M. S. Baker, X. Chen, J. R. Leventhal, and F. P. Stuart, “Sequential kidney/islet transplantation using prednisone-free immunosuppression,” American Journal of Transplantation, vol. 2, no. 7, pp. 674–677, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Ricordi, C. Fraker, J. Szust et al., “Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution,” Transplantation, vol. 75, no. 9, pp. 1524–1527, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. W. F. Ballinger and P. E. Lacy, “Transplantation of intact pancreatic islets in rats,” Surgery, vol. 72, no. 2, pp. 175–186, 1972. View at Google Scholar
  6. A. M. J. Shapiro, S. Nanji, and J. R. T. Lakey, “Clinical islet transplant: current and future directions towards tolerance,” Immunological Reviews, vol. 196, pp. 219–236, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. A. B. Peck, J. G. Cornelius, D. Schatz, and V. K. Ramiya, “Generation of islets of Langerhans from adult pancreatic stem cells,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 9, no. 6, pp. 704–709, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. N. H. McClenaghan, “Physiological regulation of the pancreatic β-cell: functional insights for understanding and therapy of diabetes,” Experimental Physiology, vol. 92, no. 3, pp. 481–496, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. G. Teitelman, S. Alpert, J. M. Polak, A. Martinez, and D. Hanahan, “Precursor cells of mouse endocrine pancreas coexpress insulin, glucagon and the neuronal proteins tyrosine hydroxylase and neuropeptide Y, but not pancreatic polypeptide,” Development, vol. 118, no. 4, pp. 1031–1039, 1993. View at Google Scholar · View at Scopus
  10. P. L. Herrera, J. Huarte, F. Sanvito, P. Meda, L. Orci, and J. D. Vassalli, “Embryogenesis of the murine endocrine pancreas; Early expression of pancreatic polypeptide gene,” Development, vol. 113, no. 4, pp. 1257–1265, 1991. View at Google Scholar · View at Scopus
  11. S. Shao, Z. Fang, X. Yu, and M. Zhang, “Transcription factors involved in glucose-stimulated insulin secretion of pancreatic beta cells,” Biochemical and Biophysical Research Communications, vol. 384, no. 4, pp. 401–404, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. K. Prasadan, S. Tulachan, P. Guo, C. Shiota, S. Shah, and G. Gittes, “Endocrine-committed progenitor cells retain their differentiation potential in the absence of neurogenin-3 expression,” Biochemical and Biophysical Research Communications, vol. 396, no. 4, pp. 1036–1041, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. G. Gradwohl, A. Dierich, M. LeMeur, F. Guillemot, and F. Guillemot, “neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 4, pp. 1607–1611, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Guney and M. Gannon, “Pancreas cell fate,” Birth Defects Research, Part C, vol. 87, no. 3, pp. 232–248, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. S. Kordowich, A. Mansouri, and P. Collombat, “Reprogramming into pancreatic endocrine cells based on developmental cues,” Molecular and Cellular Endocrinology, vol. 315, no. 1-2, pp. 11–18, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. S. Wang, J. N. Jensen, P. A. Seymour et al., “Sustained Neurog3 expression in hormone-expressing islet cells is required for endocrine maturation and function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 24, pp. 9715–9720, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. Y. Xue, C. Liu, Y. Xu et al., “Study on pancreatic islet adaptation and gene expression during pregnancy in rats,” Endocrine, vol. 37, no. 1, pp. 83–97, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. L. J. Gonez and K. R. Knight, “Cell therapy for diabetes: stem cells, progenitors or beta-cell replication?” Molecular and Cellular Endocrinology, vol. 323, no. 1, pp. 55–61, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. S. Bonner-Weir, “Life and death of the pancreatic β cells,” Trends in Endocrinology and Metabolism, vol. 11, no. 9, pp. 375–378, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Bonner-Weir, E. Toschi, A. Inada et al., “The pancreatic ductal epithelium serves as a potential pool of progenitor cells,” Pediatric Diabetes, vol. 5, no. 2, pp. 16–22, 2004. View at Google Scholar · View at Scopus
  21. S. Bonner-Weir, A. Inada, S. Yatoh et al., “Transdifferentiation of pancreatic ductal cells to endocrine β-cells,” Biochemical Society Transactions, vol. 36, no. 3, pp. 353–356, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. A. Inada, C. Nienaber, H. Katsuta et al., “Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 50, pp. 19915–19919, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. M. Solar, C. Cardalda, I. Houbracken et al., “Pancreatic exocrine duct cells give rise to insulin-producing β cells during embryogenesis but not after birth,” Developmental Cell, vol. 17, no. 6, pp. 849–860, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. D. Kopinke and L. C. Murtaugh, “Exocrine-to-endocrine differentiation is detectable only prior to birth in the uninjured mouse pancreas,” BMC Developmental Biology, vol. 10, article no. 38, 2010. View at Publisher · View at Google Scholar · View at PubMed
  25. D. T. Finegood, G. C. Weir, and S. Bonner-Weir, “Prior streptozotocin treatment does not inhibit pancreas regeneration after 90% pancreatectomy in rats,” American Journal of Physiology, vol. 276, no. 5, pp. E822–E827, 1999. View at Google Scholar · View at Scopus
  26. B. Xia, X. R. Zhan, R. Yi, and B. Yang, “Can pancreatic duct-derived progenitors be a source of islet regeneration?” Biochemical and Biophysical Research Communications, vol. 383, no. 4, pp. 383–385, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. M. Rovira, S. G. Scott, A. S. Liss, J. Jensen, S. P. Thayer, and S. D. Leach, “Isolation and characterization of centroacinar/terminal ductal progenitor cells in adult mouse pancreas,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 1, pp. 75–80, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. N. Lumelsky, O. Blondel, P. Laeng, I. Velasco, R. Ravin, and R. McKay, “Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets,” Science, vol. 292, no. 5520, pp. 1389–1394, 2001. View at Publisher · View at Google Scholar · View at PubMed
  29. S. Kim, J. S. Shin, H. J. Kim, R. C. Fisher, MI. J. Lee, and C. W. Kim, “Streptozotocin-induced diabetes can be reversed by hepatic oval cell activation through hepatic transdifferentiation and pancreatic islet regeneration,” Laboratory Investigation, vol. 87, no. 7, pp. 702–712, 2007. View at Publisher · View at Google Scholar · View at PubMed
  30. L. Yang, S. Li, H. Hatch et al., “In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 12, pp. 8078–8083, 2002. View at Publisher · View at Google Scholar · View at PubMed
  31. S. Ferber, A. Halkin, H. Cohen et al., “Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia,” Nature Medicine, vol. 6, no. 5, pp. 568–572, 2000. View at Publisher · View at Google Scholar · View at PubMed
  32. H. Kojima, M. Fujimiya, K. Matsumura et al., “NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice,” Nature Medicine, vol. 9, no. 5, pp. 596–603, 2003. View at Publisher · View at Google Scholar · View at PubMed
  33. T. Miyatsuka, H. Kaneto, Y. Kajimoto et al., “Ectopically expressed PDX-1 in liver initiates endocrine and exocrine pancreas differentiation but causes dysmorphogenesis,” Biochemical and Biophysical Research Communications, vol. 310, no. 3, pp. 1017–1025, 2003. View at Publisher · View at Google Scholar
  34. V. Yechoor, V. Liu, A. Paul et al., “Gene therapy with neurogenin 3 and betacellulin reverses major metabolic problems in insulin-deficient diabetic mice,” Endocrinology, vol. 150, no. 11, pp. 4863–4873, 2009. View at Publisher · View at Google Scholar · View at PubMed
  35. K. D. Henseleit, S. B. Nelson, K. Kuhlbrodt, J. C. Hennings, J. Ericson, and M. Sander, “NKX6 transcription factor activity is required for α- and β-cell development in the pancreas,” Development, vol. 132, no. 13, pp. 3139–3149, 2005. View at Publisher · View at Google Scholar · View at PubMed
  36. S. B. Nelson, A. E. Schaffer, and M. Sander, “The transcription factors Nkx6.1 and Nkx6.2 possess equivalent activities in promoting beta-cell fate specification in Pdx1 pancreatic progenitor cells,” Development, vol. 134, no. 13, pp. 2491–2500, 2007. View at Publisher · View at Google Scholar · View at PubMed
  37. A. C. Binot, I. Manfroid, L. Flasse et al., “Nkx6.1 and nkx6.2 regulate α- and β-cell formation in zebrafish by acting on pancreatic endocrine progenitor cells,” Developmental Biology, vol. 340, no. 2, pp. 397–407, 2010. View at Publisher · View at Google Scholar · View at PubMed
  38. S. Gefen-Halevi, I. H. Rachmut, K. Molakandov et al., “NKX6.1 promotes PDX-1-induced liver to pancreatic β-cells reprogramming,” Cellular Reprogramming, vol. 12, no. 6, pp. 655–664, 2010. View at Publisher · View at Google Scholar · View at PubMed
  39. B. Soria, E. Roche, G. Berná, T. León-Quinto, J. A. Reig, and F. Martín, “Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice,” Diabetes, vol. 49, no. 2, pp. 157–162, 2000. View at Google Scholar
  40. H. Zulewski, E. J. Abraham, M. J. Gerlach et al., “Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes,” Diabetes, vol. 50, no. 3, pp. 521–533, 2001. View at Google Scholar · View at Scopus
  41. L. Marenah, J. T. McCluskey, Y. H. A. Abdel-Wahab, F. P. M. O'Harte, N. H. McClenaghan, and P. R. Flatt, “A stable analogue of glucose-dependent insulinotropic polypeptide, GIP(LysPAL), enhances functional differentiation of mouse embryonic stem cells into cells expressing islet-specific genes and hormones,” Biological Chemistry, vol. 387, no. 7, pp. 941–947, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. J. Rajagopal, W. J. Anderson, S. Kume, O. I. Martinez, and D. A. Melton, “Development: Insulin staining of ES cell progeny from insulin uptake,” Science, vol. 299, no. 5605, p. 363, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. M. Hansson, A. Tonning, U. Frandsen et al., “Artifactual insulin release from differentiated embryonic stem cells,” Diabetes, vol. 53, no. 10, pp. 2603–2609, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Sipionei, A. Eshpeter, J. G. Lyon, G. S. Korbutt, and R. C. Bleackley, “Insulin expressing cells from differentiated embryonic stem cells are not beta cells,” Diabetologia, vol. 47, no. 3, pp. 499–508, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. E. McKiernan, L. O'Driscoll, M. Kasper, N. Barron, F. O'Sullivan, and M. Clynes, “Directed differentiation of mouse embryonic stem cells into pancreatic-like or neuronal- and glial-like phenotypes,” Tissue Engineering, vol. 13, no. 10, pp. 2419–2430, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. Y. Hori, I. C. Rulifson, B. C. Tsai, J. J. Heit, J. D. Cahoy, and S. K. Kim, “Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 25, pp. 16105–16110, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. S. Miyazaki, E. Yamato, and J. I. Miyazaki, “Regulated expression of pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells,” Diabetes, vol. 53, no. 4, pp. 1030–1037, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. P. Blyszczuk, J. Czyz, G. Kania et al., “Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 3, pp. 998–1003, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. A. Rezania, M. J. Riedel, R. D. Wideman et al., “Production of functional glucagon-secreting α-cells from human embryonic stem cells,” Diabetes, vol. 60, no. 1, pp. 239–247, 2011. View at Publisher · View at Google Scholar · View at PubMed
  50. S. Yamanaka, “Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors,” Cell Proliferation, vol. 41, no. 1, pp. 51–56, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. K. Takahashi, K. Tanabe, M. Ohnuki et al., “Induction of pluripotent stem cells from adult human fibroblasts by defined factors,” Cell, vol. 131, no. 5, pp. 861–872, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. N. Maherali and K. Hochedlinger, “Induced pluripotency of mouse and human somatic cells,” Cold Spring Harbor Symposia on Quantitative Biology, vol. 73, pp. 157–162, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. Z. Alipio, W. Liao, E. J. Roemer et al., “Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic β-like cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 30, pp. 13426–13431, 2010. View at Publisher · View at Google Scholar · View at PubMed
  54. D. Zhang, W. Jiang, M. Liu et al., “Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells,” Cell Research, vol. 19, no. 4, pp. 429–438, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. M. Stadtfeld, K. Brennand, and K. Hochedlinger, “Reprogramming of pancreatic β cells into induced pluripotent stem cells,” Current Biology, vol. 18, no. 12, pp. 890–894, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. R. Maehr, S. Chen, M. Snitow et al., “Generation of pluripotent stem cells from patients with type 1 diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 37, pp. 15768–15773, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. R. Lister, M. Pelizzola, Y. S. Kida et al., “Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells,” Nature, vol. 471, no. 7336, pp. 68–73, 2011. View at Publisher · View at Google Scholar · View at PubMed
  58. C. Kelly, H. Guo, J. T. McCluskey, P. R. Flatt, and N. H. McClenaghan, “Comparison of insulin release from MIN6 pseudoislets and pancreatic islets of langerhans reveals importance of homotypic cell interactions,” Pancreas, vol. 39, no. 7, pp. 1016–1023, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. H. C. Brereton, M. J. Carvell, H. Asare-Anane et al., “Homotypic cell contact enhances insulin but not glucagon secretion,” Biochemical and Biophysical Research Communications, vol. 344, no. 3, pp. 995–1000, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. C. Kelly, N. H. McClenaghan, and P. R. Flatt, “Role of islet structure and cellular interactions in the control of insulin secretion,” Islets, vol. 3, no. 2, pp. 41–47, 2011. View at Publisher · View at Google Scholar
  61. S. Gerecht-Nir, S. Osenberg, O. Nevo, A. Ziskind, R. Coleman, and J. Itskovitz-Eldor, “Vascular development in early human embryos and in teratomas derived from human embryonic stem cells,” Biology of Reproduction, vol. 71, no. 6, pp. 2029–2036, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. M. Rodriguez-Porcel, “In vivo imaging and monitoring of transplanted stem cells: clinical applications,” Current Cardiology Reports, vol. 12, no. 1, pp. 51–58, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. N. Irwin and P. R. Flatt, “Therapeutic potential for GIP receptor agonists and antagonists,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 23, no. 4, pp. 499–512, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. K. A. D'Amour, A. G. Bang, S. Eliazer et al., “Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells,” Nature Biotechnology, vol. 24, no. 11, pp. 1392–1401, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus